DƯỢC LÍ Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th, 2010

Slater EE, Merrill DD, Guess HA, et al. Clinical profile of
angioedema associated with angiotensin-converting enzyme
inhibition. JAMA, 1988, 260:967–970.
Stewart JM. Bradykinin antagonists: Discovery and development.
Peptides, 2004, 25:527–532.
Takada Y, Skidgel RA, Erdös EG. Purification of human urinary
prokallikrein. Identification of the site of activation by the metalloproteinase
thermolysin. Biochem J, 1985, 232:851–858.
Takagaki Y, Kitamura N, Nakanishi S. Cloning and sequence
analysis of cDNAs for human high molecular weight and low
molecular weight prekininogens: Primary structures of two
human prekininogens. J Biol Chem, 1985, 260:8601–8609.
Thurmond RL, Gelfand EW, Dunford PJ. The role of histamine
H1 and H4 receptors in allergic inflammation: The search for
new antihistamines. Nat Rev Drug Discov, 2008, 7:41–53.
Waxler B, Rabito SF. Aprotinin: A serine protease inhibitor with
therapeutic actions: Its interaction with ACE inhibitors. Curr
Pharm Des, 2003, 9:777–787.
Werle E. Discovery of the most important kallikreins and
kallikrein inhibitors. In: Erdös EG, ed. Bradykinin, Kallidin and
Kallikrein. In: Handbook of Experimental Pharmacology, Vol.
25. Berlin, Springer-Verlag, 1970, pp. 1–6.
Widdop RE, Jones ES, Hannan RE, Gaspari TA. Angiotensin
AT 2
receptors: Cardiovascular hope or hype? Br J Pharmacol,
2003, 140:809–824.
Yang HYT, Erdös EG, Levin Y. A dipeptidyl carboxypeptidase
that converts angiotensin I and inactivates bradykinin. Biochim
Biophys Acta, 1970, 214:374–376.
Zhang X, Tan F, Zhang Y, Skidgel RA. Carboxypeptidase M and
kinin B1 receptors interact to facilitate efficient B1 signaling
from B2 agonists. J Biol Chem, 2008, 283:7994–8004.
Zhang Y, Brovkovych V, Brovkovych S, et al. Dynamic receptordependent
activation of inducible nitric-oxide synthase by
ERK-mediated phosphorylation of Ser745. J Biol Chem, 2007,
282:32453–32461.
935
CHAPTER 32
HISTAMINE, BRADYKININ, AND THEIR ANTAGONISTS